Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer
PHASE2
The study is open label, phase II clinical trial for the Combination of GX-...
Status
Active Not Recruiting
Location
Yonsei University Health System, Severance Hospital
HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy
PHASE2
This study is to explore the efficacy and safety of GX-188E DNA vaccination...
Status
Active Not Recruiting
Location
Yonsei University Health System, Severance Hospital